Search the web
Sign In
New User? Sign Up
ChildhoodCancerTheCause · Childhood Cancer Causation.
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Hear how Yahoo! Groups has changed the lives of others. Take me there.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
Fwd: T cell targeted therapy symposium in Orlando - REGISTER NOW!   Message List  
Reply | Forward Message #178 of 558 |






Tue Nov 7, 2006 10:32 pm

hope4kids2
Offline Offline
Send Email Send Email

Targeting T Cells: New Paradigms in the Treatment of Lymphoproliferative Disorders and Transplantation
Preceding the 48th Annual Meeting of the American Society of Hematology
 
Friday, December 8, 2006 - Rosen Centre Hotel - Orlando, FL
Registration and Lunch 12:30 - 1:45 pm: Program and Q&A Session 1:45 - 4:30 pm

Find out how using T cell targeted therapy can reduce side effects and optimize outcomes
Faculty will review scientific research and clinical developments in the
application of T cell-targeting therapeutic management. You’ll learn new
treatment advances that combine chemotherapy and microbiological
advances in monoclonal antibodies (MAbs) while targeting CD2 to facilitate
cancerous T cell depletion and healthy T cell preservation. View agenda

After completing this course, you should be able to:
Describe the pathophysiology of aggressive T cell-mediated lymphoproliferative disease

Evaluate research derived from pre-clinical anti-CD2 T cell models

Identify clinical applications of MAb therapies and their effect
on transplantation

Define the clinical application of CD2-mediated T cell depletion in the treatment of non-Hodgkin’s lymphoma (NHL), other cancers as well as
in stem cell transplantation

Recognize the need for ongoing research into T cell-mediated
MAb therapy

Space is limited; reserve your seat today!
hemonctoday.com/tcells
1-877-307-5225 856-994-9400
E-mail: MeetingRegistration@...

Course Director

Francine Foss, MD
Professor of Medicine
Assistant Director
Clinical Investigation
Hematological Malignancies
Yale University Cancer Center
Section of Medical Oncology
New Haven, Connecticut


Faculty

Randy Gascoyne, MD, PhD
Vancouver, British Columbia,
Canada

John E. Janik, MD
Bethesda, Maryland

Thomas R. Spitzer, MD
Boston, Massachusetts

Megan Sykes, MD
Boston, Massachusetts

Meili Zhang, PhD
Bethesda, Maryland



 
This CME activity is jointly sponsored by
Vindico Medical Education [logo] Hem/Onc Today [logo]
 

Supported by an
educational grant from


MedImmune [logo]
 
 

ACCREDITATION: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and HEM/ONC TODAY. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this educational activity for a maximum of 2.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule, and credit hours are subject to change. Audio taping or video taping is prohibited without written permission from the program director and the Office of Medical Education and Compliance.


 

If you have received this in error or would like to unsubscribe, please click here.



Tue Nov 7, 2006 6:54 pm

HEMONC-SysAdmin@...
Send Email Send Email
Forward
Message #178 of 558 |
Expand Messages Author Sort by Date

<http://www.hemonctoday.com/tcells> Targeting T Cells: New Paradigms in the Treatment of Lymphoproliferative Disorders and Transplantation Preceding the 48th...
Hope4Kids2@...
hope4kids2
Offline Send Email
Nov 7, 2006
10:42 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help